Ceruloplasmin replacement therapy

Aceruloplasminemia is a monogenic disease produced by mutations in the ceruloplasmin gene that result in loss of protein ferroxidase activityCeruloplasmin plays a big role in iron homeostasis, and its activity impairment leads to iron accumulation in liver, pancreas, and brain. Iron deposition promotes degeneration, diabetes, and progressive neurodegeneration.

 

    Related Conference of Ceruloplasmin replacement therapy

    Ceruloplasmin replacement therapy Conference Speakers